Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05264246 · ClinicalTrials.gov registry record
Evaluation of an Anti-Shivering Protocol Cardiac Arrest
A clinical trial, sponsored by Methodist Health System.
- Terminated
- Registry status
- 165
- Enrollment target
NCT05264246: Clinical Trial study, sponsored by Methodist Health System.
NCT05264246 is a clinical trial that was terminated before completion, run by Methodist Health System. The registered enrollment target is 165 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05264246 was terminated before completion, sponsored by Methodist Health System.
- TERMINATED
- Registry status
- 165 participants
- Enrollment target
Study Summary
This will be a single center, retrospective, before-and-after, chart review of all patients undergoing TTM between June 1, 2017 and May 31, 2021 at MDMC. Initiation of the new TTM protocol occurred on April 22, 2019.
Primary Outcome
vecuronium or cisatracurium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2021-09-15 |
| Est. Completion | 2024-09-09 |
Why NCT05264246 stopped before completion
NCT05264246 is an observational study that tracks outcomes without assigning an intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT05264246 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05264246 about?
NCT05264246 is a clinical study titled "Evaluation of an Anti-Shivering Protocol Cardiac Arrest". This will be a single center, retrospective, before-and-after, chart review of all patients undergoing TTM between June 1, 2017 and May 31, 2021 at MDMC. Initiation of the new TTM protocol occurred on April 22, 2019.
What is the current status of trial NCT05264246?
This trial is currently terminated. The enrollment target is 165 participants. The study started on 2021-09-15. Estimated completion is 2024-09-09.
Who is sponsoring clinical trial NCT05264246?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02387255 · 165 participants
Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms
- NCT03351348 · 165 participants · Phase 3
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
- NCT03830320 · 165 participants · Phase 1
Positron Emission Tomography (PET) Imaging of Thrombosis
- NCT04289571 · 165 participants · Phase 1
Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI